LUMOS PHARMA, INC. (LUMO) Nonoperating Income (Expense) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lumos Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2024.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $421 K, a 38.9% decline year-over-year.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $2.28 M, a 39% increase year-over-year.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $2.55 M, a 164% increase from 2022.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $965 K, a 243% increase from 2021.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $281 K, a 95.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.28 M $421 K -$268 K -38.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.55 M $547 K -$28 K -4.87% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $2.58 M $632 K +$333 K +111% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.25 M $683 K +$603 K +754% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.64 M $689 K +$678 K +6164% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $965 K $575 K +$283 K +96.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $682 K $299 K +$290 K +3222% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $392 K $80 K +$86 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $306 K $11 K +$25 K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $281 K $292 K +$305 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$24 K $9 K -$6.48 M -99.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.46 M -$6 K -$104 K -106% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $6.56 M -$14 K -$106 K -115% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $6.67 M -$13 K -$36 K -157% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $6.7 M $6.49 M +$6.46 M +22279% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $242 K $98 K +$72 K +277% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $170 K $92 K +$59 K +179% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $111 K $23 K -$377 K -94.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $488 K $29 K -$615 K -95.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.1 M $26 K -$409 K -94% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.51 M $33 K -$363 K -91.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-02
Q4 2018 $1.88 M $400 K +$165 K +70.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 $1.71 M $644 K +$484 K +303% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.23 M $435 K +$434 K +43400% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $792 K $396 K +$421 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $371 K $235 K +$106 K +82.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $265 K $160 K +$141 K +742% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $124 K $1 K -$59 K -98.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $183 K -$25 K -$64 K -164% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $247 K $129 K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-05
Q3 2016 $19 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $60 K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $39 K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.